How does the law protect vulnerable populations from biomedical research exploitation?

Biomedical research exploitation occurs when those involved in medical research use or manipulate people, harming them in the process. To protect vulnerable populations from exploitation, New Hampshire has several laws in place. First, the state has the Human Subjects Protection Act, also known as the Belmont Report. This act states that research involving vulnerable populations, such as children, must be conducted ethically and with the informed consent of those involved. The act also sets forth certain requirements for the protection of these vulnerable populations, such as a review board for all research projects involving children. This review board is tasked with reviewing all aspects of proposed research to ensure it complies with ethical standards. In addition, New Hampshire also enforces the Genetic Information Nondiscrimination Act, or GINA. GINA was created to protect people participating in or affected by genetic testing from discrimination based on the results of the tests. This includes discrimination from employers, health insurance companies, or educational institutions. Finally, the state also requires the use of Institutional Review Board (IRB) when conducting research on vulnerable populations. Because IRB ensures that research procedures are fair and protects the rights of participants. These protections help ensure that vulnerable populations are treated fairly and that their rights are not violated. This helps to prevent exploitation and keeps medical research safe and ethical.

Related FAQs

What is the scope of legal protection for undocumented immigrants in biomedical research?
Are there any special considerations regarding biomedical law and health insurance?
What are the current issues in biomedical law?
Are there any special considerations regarding the use of children in biomedical research?
What is the scope of legal protection for medically assisted reproductive technologies?
How does the law protect vulnerable populations from biomedical research exploitation?
What is the scope of legal protection for research and development involving tissue or organs derived from biobanking?
What are the legal protections for whistleblowers in biomedical research?
What is the scope of legal protection for genetic therapies derived from biomedical research?
How does the law protect the rights of participants in biomedical research?

How does the law protect vulnerable populations from biomedical research exploitation?

Related FAQs

Related Blog Posts